K+ channel-blocking alkoxypsoralens inhibit the immune response of encephalitogenic T line cells and lymphocytes from Lewis rats challenged for experimental autoimmune encephalomyelitis

Immunopharmacology

Volumn 48, Issue 1, 2000, Pages 51-63

  Strauss, Ulf ^a   Wissel, Kirsten ^a   Jung, Stefan ^b   Wulff, Heike ^c   Hänsel, Wolfram ^c   Zhu, Jie ^d   Rolfs, Arndt ^a   Mix, Eilhard ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alkoxypsoralens; Experimental autoimmune encephalomyelitis; Interferon ; K+ channels; Lymphocyte proliferation

Indexed keywords

5,8 DIETHOXYPSORALEN; BERGAPTEN; ENCEPHALITOGENIC PROTEIN; GAMMA INTERFERON; METHOXSALEN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PSORALEN DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

4-AMINOPYRIDINE; ANIMALS; CELL LINE; CONCANAVALIN A; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; METHOXSALEN; MYELIN BASIC PROTEINS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; PSORALENS; RATS; RATS, INBRED LEW; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0034020420     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)00177-6     Document Type: Article

References (38)

1. Arslan P., Cantini M., Cossarizza A., Franceschi C., Dall'Acqua F. Diverse effects of three furocoumarins on human lymphocyte proliferation. Life Sci. 44:1989;2097-2104.
2. Averbeck D. Recent advances in psoralen phototoxicity mechanism. Photochem. Photobiol. 50:1989;859-882.
3. Bauer P., Regitz-Zagrosek V., Hofmeister J., Lokies J., Rolfs A., Hildebrandt A.G., Hetzer R., Fleck E. Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure: assessment by a novel quantitative PCR-ELISA technique. J. Mol. Med. 74:1996;447-454.
4. Beijersbergen van Henegouwen G.M.J., Wijin E.T., Schoonderwoerd S.A., Dall'Acqua F. Method for the determination of the in vivo irreversible binding of 8-methoxypsoralen (8-MOP) to epidermal lipids, proteins and DNA/RNA after PUVA treatment. J. Photochem. Photobiol., B: Biol. 3:1989;631-635.
5. Bohuslavizki K.H., Hänsel W., Kneip A., Koppenhöfer E., Reimers A., Sanmann K. Blocking of potassium channels in Ranvier nodes by 4,5,6,7-substituted benzofurans and its significance on demyelinating diseases. Gen. Physiol. Biophys. 12:1993;293-301.
6. Cahalan M.D., Chandy K.G. Ion channels in the immune system as targets for immunosuppression. Curr. Opin. Biotechnol. 8:1997;749-756.
7. Cahalan M.D., Chandy K.G., DeCoursey T.E., Gupta S. A voltage-gated potassium channel in human T lymphocytes. J. Physiol. (London). 358:1985;197-237.
8. Chandy K.G., DeCoursey T.E., Cahalan M.D., McLaughlin C., Gupta S. Voltage-gated potassium channels are required for human T lymphocyte activation. J. Exp. Med. 160:1984;369-385.
9. Chandy K.G., Gutman G.A. Voltage gated potassium channel genes. North R.A. Handbook of Receptors and Channels. 1995;1-71 CRC Press, Boca Raton.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Cox G.W., Orosz C.G., Fertel R.H. 8-Methoxypsoralen inhibits lymmphocyte proliferation in vitro in the absence of ultraviolet radiation. Int. J. Immunopharmacol. 9:1987;475-481.
12. + channels in human T lymphocytes: a role in mitogenesis? Nature. 307:1984;465-468.
13. + channels in human lymphocytes. Biochem. Biophys. Res. Commun. 213:1995;419-423.
14. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflueger's Arch. 391:1981;85-100.
15. Hille B. Ionic channels of exitable membranes. 2nd edn. 1992;Sinauer Associates, Sunderland.
16. Issazadeh S., Mustafa M., Ljungdahl A., Höjeberg B., Dagerlind A., Elde R., Olsson T. Interferon-γ, interleukin-4 and transforming growth factor-β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res. 40:1995;579-590.
17. Jung S., Krämer S., Schlüsener H.J., Hünig T., Toyka K., Hartung H.P. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta. J. Immunol. 148:1992;3768-3775.
18. 2+ channel in Jurkat T lymphocytes. Science. 283:1999;836-839.
19. Koo G.C., Blake J.T., Talento A., Nguyen M., Lin S., Sirotina A., Shah K., Mulvany K., Hora J., Cunningham P., Wunderler D., McManus O.B., Slaughter R., Buiganesi R., Felix J., Garcia M., Williamson J., Kaczorowski G., Sigal N., Springer M., Feeney W. Blockade of the voltage gated potassium channel Kv 1.3 inhibits immune response in vivo. J. Immunol. 158:1997;5120-5128.
20. Lewis R.S., Cahalan M.D. Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol. 13:1995;623-653.
21. Link H. The cytokine storm in multiple sclerosis. Mult. Scler. 4:1998;12-15.
22. Martin R., McFarland H.F. Immunology of multiple sclerosis and experimental allergic encephalomyelitis. Raine C.S., McFarland H.F., Tourtellotte W.W. Multiple Sclerosis. Clinical and Pathogenetic Basis. 1997;221-242 Chapman & Hall Medical, London.
23. McCombe P.A., Nickson I., Pender M.P. Cytokine expression by inflammatory cells obtained from the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein and adjuvants. J. Neuroimmunol. 88:1998;30-38.
24. Michne W.F., Guiles J.W., Treasurywala A.M., Castonguay L.A., Weigelt C.A., Oconnor B., Volberg W.A., Grant A.M., Chadwick C.C., Krafte D.S., Hill R.J. Novel inhibitors of potassium ion channels on human T lymphocytes. J. Med. Chem. 38:1995;1877-1883.
25. Moore R.E., Shephard J.W., Hoskins J. Design of primers that detect only mRNA in the presence of DNA. Nucleic Acids Res. 18:1990;1921.
26. Norton W.T., Poduslo S.E. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:1973;749-757.
27. + channel characteristics in human T cells: perforated-patch versus whole-cell recording techniques. J. Membr. Biol. 132:1993;229-241.
28. Olsson T., Zhi W.W., Höjeberg B., Kostulas V., Jiang Y.P., Anderson G., Ekre H.P., Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J. Clin. Invest. 86:1990;981-985.
29. Renno T., Lin J.-Y., Piccirillo C., Antel J., Owens T. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49:1994;1-7.
30. Rolfs A., Schuller I., Finckh U., Weber-Rolfs I. Site directed mutagenesis using the PCR. Rolfs A., Schuller I., Finckh U., Weber-Rolfs I. PCR: Clinical Diagnostics and Research. 1992;216-218 Springer Verlag, Berlin.
31. + currents of encephalitogenic memory T cells decrease with encephalitogenicity while interleukin-2 (IL-2) receptor expression remains stable during IL-2 dependent cell expansion. Receptors Channels. 6:1998;73-87.
32. 2+ signaling. Cell Calcium. 17:1995;287-300.
33. Woodroofe M.N., Cuzner M.L. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine. 5:1993;583-588.
34. Wulff H., Koppenhöfer E., Hänsel W. Potassium channel blocking psoralens, benzofurans, acridones and coumarins for the treatment of multiple sclerosis and related diseases. Curr. Res. Ion Channel Modul. 3:1998;207-212.
35. + channels: synthesis and photoreactivity. J. Med. Chem. 41:1998;4542-4549.
36. Wulff H., Rauer H., Hanselmann C., Ruff K., Wrisch A., Grissmer S., Hänsel W. 5-Alkoxypsoralens - A new class of nonpeptide blockers of potassium channels of the shaker and shaw family. Naunyn-Schmiedeberg's Arch. Pharmacol. 358(2):1998;R697.
37. Zajdela F., Bisagni E. 5-Methoxypsoralen, the melanogenic additive in sun-tan preparations, is tumorigenic in mice exposed to 365 nm u.v. radiation. Carcinogenesis. 2:1981;121-127.
38. Zarebska Z. Cell membrane, a target for PUVA therapy. J. Photochem. Photobiol., B: Biol. 23:1994;101-109.